Leah E. Appel
17Patents
6h-index
30Co-inventors
66Inventor score
Filing activity: Jun 22, 1992 → Mar 9, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6706283B1 | Controlled release by extrusion of solid amorphous dispersions of drugs | Human Necessities | 116 | Expired |
| US6984403B2 | Azithromycin dosage forms with reduced side effects | Human Necessities | 60 | Expired |
| US5256440A | Process for producing a tablet core aperture | Human Necessities | 43 | Expired |
| US7550158B2 | Controlled release by extrusion of solid amorphous dispersions of drugs | Human Necessities | 17 | Expired |
| US9211261B2 | Immediate release dosage forms containing solid drug dispersions | Human Necessities | 13 | Active |
| US7625507B2 | Extrusion process for forming chemically stable drug multiparticulates | Human Necessities | 8 | Expired |
| US7887844B2 | Multiparticulate crystalline drug compositions having controlled release profiles | Human Necessities | 6 | Active |
| US7736672B2 | Multiparticulate compositions with improved stability | Human Necessities | 6 | Active |
| US7951403B2 | Method of making pharmaceutical multiparticulates | Human Necessities | 2 | Active |
| US9028870B2 | Hydrogel-driven drug dosage form | Human Necessities | 1 | Active |
| US11154521B2 | Palatable compositions including sodium phenylbutyrate and uses thereof | Human Necessities | 0 | Active |
| US11433041B2 | Palatable compositions including sodium phenylbutyrate and uses thereof | Human Necessities | 0 | Active |
| US11116728B2 | Multiparticulates of spray-coated drug and polymer on a meltable core | Human Necessities | 0 | Active |
| US10357462B2 | Multiparticulates of spray-coated drug and polymer on a meltable core | Human Necessities | 0 | Active |
| US11202767B2 | Methods of treating urea cycle disorders and maple syrup urine disease | Human Necessities | 0 | Active |
| US8236349B2 | Taste-masked drugs in rupturing multiparticulates | Human Necessities | 0 | Active |
| US9445998B2 | Pharmaceutical dosage forms comprising a low-solubility drug and a polymer | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.